Market Insights Health Hospitals Inpatient Care

Gastroenterology - G20

The Gastroenterology market in the G20 countries is anticipated to witness a significant surge in revenue, with projections indicating that it will reach a staggering US$169.80bn by the year 2024.
Moreover, this market is expected to exhibit a steady annual growth rate (CAGR 2024-2029) of 2.66%, leading to a substantial increase in market volume, estimated to reach US$193.60bn by 2029.
When comparing the revenue generated globally, it becomes evident that United States emerges as the frontrunner in this market, with an impressive revenue of US$60,480.00m projected for the year 2024.
In the Gastroenterology market, Japan leads the way with its innovative endoscopic technologies and high patient satisfaction rates.

Key regions: France, China, Japan, United States, Europe

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.